Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 276 entries
Sorted by: Best Match Show Resources per page
Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening.

Nature communications

Machutta CA, Kollmann CS, Lind KE, Bai X, Chan PF, Huang J, Ballell L, Belyanskaya S, Besra GS, Barros-Aguirre D, Bates RH, Centrella PA, Chang SS, Chai J, Choudhry AE, Coffin A, Davie CP, Deng H, Deng J, Ding Y, Dodson JW, Fosbenner DT, Gao EN, Graham TL, Graybill TL, Ingraham K, Johnson WP, King BW, Kwiatkowski CR, Lelièvre J, Li Y, Liu X, Lu Q, Lehr R, Mendoza-Losana A, Martin J, McCloskey L, McCormick P, O'Keefe HP, O'Keeffe T, Pao C, Phelps CB, Qi H, Rafferty K, Scavello GS, Steiginga MS, Sundersingh FS, Sweitzer SM, Szewczuk LM, Taylor A, Fern Toh M, Wang J, Wang M, Wilkins DJ, Xia B, Yao G, Zhang J, Zhou J, Donahue CP, Messer JA, Holmes D, Arico-Muendel CC, Pope AJ, Gross JW, Evindar G.
PMID: 30004092
Nat Commun. 2018 Jul 13;9:16227. doi: 10.1038/ncomms16227.

This corrects the article DOI: 10.1038/ncomms16081.

Cite
Machutta CA, Kollmann CS, Lind KE, et al. Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nat Commun. 2018;9:16227doi: 10.1038/ncomms16227.
Machutta, C. A., Kollmann, C. S., Lind, K. E., Bai, X., Chan, P. F., Huang, J., Ballell, L., Belyanskaya, S., Besra, G. S., Barros-Aguirre, D., Bates, R. H., Centrella, P. A., Chang, S. S., Chai, J., Choudhry, A. E., Coffin, A., Davie, C. P., Deng, H., Deng, J., Ding, Y., Dodson, J. W., Fosbenner, D. T., Gao, E. N., Graham, T. L., Graybill, T. L., Ingraham, K., Johnson, W. P., King, B. W., Kwiatkowski, C. R., Lelièvre, J., Li, Y., Liu, X., Lu, Q., Lehr, R., Mendoza-Losana, A., Martin, J., McCloskey, L., McCormick, P., O'Keefe, H. P., O'Keeffe, T., Pao, C., Phelps, C. B., Qi, H., Rafferty, K., Scavello, G. S., Steiginga, M. S., Sundersingh, F. S., Sweitzer, S. M., Szewczuk, L. M., Taylor, A., Fern Toh, M., Wang, J., Wang, M., Wilkins, D. J., Xia, B., Yao, G., Zhang, J., Zhou, J., Donahue, C. P., Messer, J. A., Holmes, D., Arico-Muendel, C. C., Pope, A. J., Gross, J. W., & Evindar, G. (2018). Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nature communications, 916227. https://doi.org/10.1038/ncomms16227
Machutta, Carl A, et al. "Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening." Nature communications vol. 9 (2018): 16227. doi: https://doi.org/10.1038/ncomms16227
Machutta CA, Kollmann CS, Lind KE, Bai X, Chan PF, Huang J, Ballell L, Belyanskaya S, Besra GS, Barros-Aguirre D, Bates RH, Centrella PA, Chang SS, Chai J, Choudhry AE, Coffin A, Davie CP, Deng H, Deng J, Ding Y, Dodson JW, Fosbenner DT, Gao EN, Graham TL, Graybill TL, Ingraham K, Johnson WP, King BW, Kwiatkowski CR, Lelièvre J, Li Y, Liu X, Lu Q, Lehr R, Mendoza-Losana A, Martin J, McCloskey L, McCormick P, O'Keefe HP, O'Keeffe T, Pao C, Phelps CB, Qi H, Rafferty K, Scavello GS, Steiginga MS, Sundersingh FS, Sweitzer SM, Szewczuk LM, Taylor A, Fern Toh M, Wang J, Wang M, Wilkins DJ, Xia B, Yao G, Zhang J, Zhou J, Donahue CP, Messer JA, Holmes D, Arico-Muendel CC, Pope AJ, Gross JW, Evindar G. Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nat Commun. 2018 Jul 13;9:16227. doi: 10.1038/ncomms16227. PMID: 30004092; PMCID: PMC6054520.
Copy Download .nbib Format: NLM
Enhanced light-matter interaction in an atomically thin semiconductor coupled with dielectric nano-antennas.

Nature communications

Sortino L, Zotev PG, Mignuzzi S, Cambiasso J, Schmidt D, Genco A, Aßmann M, Bayer M, Maier SA, Sapienza R, Tartakovskii AI.
PMID: 31712619
Nat Commun. 2019 Nov 11;10(1):5119. doi: 10.1038/s41467-019-12963-3.

Unique structural and optical properties of atomically thin two-dimensional semiconducting transition metal dichalcogenides enable in principle their efficient coupling to photonic cavities having the optical mode volume close to or below the diffraction limit. Recently, it has become possible...

Cite
Sortino L, Zotev PG, Mignuzzi S, et al. Enhanced light-matter interaction in an atomically thin semiconductor coupled with dielectric nano-antennas. Nat Commun. 2019;10(1):5119doi: 10.1038/s41467-019-12963-3.
Sortino, L., Zotev, P. G., Mignuzzi, S., Cambiasso, J., Schmidt, D., Genco, A., Aßmann, M., Bayer, M., Maier, S. A., Sapienza, R., & Tartakovskii, A. I. (2019). Enhanced light-matter interaction in an atomically thin semiconductor coupled with dielectric nano-antennas. Nature communications, 10(1), 5119. https://doi.org/10.1038/s41467-019-12963-3
Sortino, L, et al. "Enhanced light-matter interaction in an atomically thin semiconductor coupled with dielectric nano-antennas." Nature communications vol. 10,1 (2019): 5119. doi: https://doi.org/10.1038/s41467-019-12963-3
Sortino L, Zotev PG, Mignuzzi S, Cambiasso J, Schmidt D, Genco A, Aßmann M, Bayer M, Maier SA, Sapienza R, Tartakovskii AI. Enhanced light-matter interaction in an atomically thin semiconductor coupled with dielectric nano-antennas. Nat Commun. 2019 Nov 11;10(1):5119. doi: 10.1038/s41467-019-12963-3. PMID: 31712619; PMCID: PMC6848120.
Copy Download .nbib Format: NLM
Gated Transformer for Decoding Human Brain EEG Signals.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Tao Y, Sun T, Muhamed A, Genc S, Jackson D, Arsanjani A, Yaddanapudi S, Li L, Kumar P.
PMID: 34891254
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:125-130. doi: 10.1109/EMBC46164.2021.9630210.

In this work, we propose to use a deep learning framework for decoding the electroencephalogram (EEG) signals of human brain activities. More specifically, we learn an end-to-end model that recognizes natural images or motor imagery by the EEG data...

Cite
Tao Y, Sun T, Muhamed A, et al. Gated Transformer for Decoding Human Brain EEG Signals. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:125-130doi: 10.1109/EMBC46164.2021.9630210.
Tao, Y., Sun, T., Muhamed, A., Genc, S., Jackson, D., Arsanjani, A., Yaddanapudi, S., Li, L., & Kumar, P. (2021). Gated Transformer for Decoding Human Brain EEG Signals. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2021125-130. https://doi.org/10.1109/EMBC46164.2021.9630210
Tao, Yunzhe, et al. "Gated Transformer for Decoding Human Brain EEG Signals." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2021 (2021): 125-130. doi: https://doi.org/10.1109/EMBC46164.2021.9630210
Tao Y, Sun T, Muhamed A, Genc S, Jackson D, Arsanjani A, Yaddanapudi S, Li L, Kumar P. Gated Transformer for Decoding Human Brain EEG Signals. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:125-130. doi: 10.1109/EMBC46164.2021.9630210. PMID: 34891254.
Copy Download .nbib Format: NLM
The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease.

American journal of otolaryngology

Durgut O, Karataş M, Çelik Ç, Dikici O, Solmaz F, Gencay S.
PMID: 34922259
Am J Otolaryngol. 2021 Dec 14;43(2):103320. doi: 10.1016/j.amjoto.2021.103320. Epub 2021 Dec 14.

INTRODUCTION: COVID-19 may have many nonspecific symptoms, such as hearing loss, tinnitus and dizziness. This study aims to investigate the effects of SARS-CoV-2 on the hearing thresholds of patients with COVID-19.METHODS: A total of 20 patients aged 20-55 years...

Cite
Durgut O, Karataş M, Çelik Ç, et al. The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease. Am J Otolaryngol. 2021;43(2):103320doi: 10.1016/j.amjoto.2021.103320.
Durgut, O., Karataş, M., Çelik, �. �., Dikici, O., Solmaz, F., & Gencay, S. (2021). The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease. American journal of otolaryngology, 43(2), 103320. https://doi.org/10.1016/j.amjoto.2021.103320
Durgut, Osman, et al. "The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease." American journal of otolaryngology vol. 43,2 (2021): 103320. doi: https://doi.org/10.1016/j.amjoto.2021.103320
Durgut O, Karataş M, Çelik Ç, Dikici O, Solmaz F, Gencay S. The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease. Am J Otolaryngol. 2021 Dec 14;43(2):103320. doi: 10.1016/j.amjoto.2021.103320. Epub 2021 Dec 14. PMID: 34922259; PMCID: PMC8669941.
Copy Download .nbib Format: NLM
Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis.

Clinical and experimental gastroenterology

Tarlarini C, Penco S, Conio M, Grossi E.
PMID: 22893750
Clin Exp Gastroenterol. 2012;5:159-66. doi: 10.2147/CEG.S32610. Epub 2012 Aug 08.

BACKGROUND: Barrett's esophagus (BE), a metaplastic premalignant disorder, represents the primary risk factor for the development of esophageal adenocarcinoma. Chronic gastroesophageal reflux disease and central obesity have been associated with BE and esophageal adenocarcinoma, but relatively little is known...

Cite
Tarlarini C, Penco S, Conio M, et al. Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis. Clin Exp Gastroenterol. 2012;5:159-66doi: 10.2147/CEG.S32610.
Tarlarini, C., Penco, S., Conio, M., & Grossi, E. (2012). Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis. Clinical and experimental gastroenterology, 5159-66. https://doi.org/10.2147/CEG.S32610
Tarlarini, Claudia, et al. "Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis." Clinical and experimental gastroenterology vol. 5 (2012): 159-66. doi: https://doi.org/10.2147/CEG.S32610
Tarlarini C, Penco S, Conio M, Grossi E. Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis. Clin Exp Gastroenterol. 2012;5:159-66. doi: 10.2147/CEG.S32610. Epub 2012 Aug 08. PMID: 22893750; PMCID: PMC3418826.
Copy Download .nbib Format: NLM
Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy.

Scientific reports

Consuegra I, Gasco S, Serramía MJ, Jiménez JL, Mellado MJ, Muñoz-Fernández MÁ.
PMID: 34873266
Sci Rep. 2021 Dec 06;11(1):23477. doi: 10.1038/s41598-021-03020-5.

miRNAs have been extensively studied in pathological conditions, including viral infections, such as those provoked by HIV-1. Several cellular and circulating miRNAs are altered during HIV-1 infection, with either beneficial effects on host defenses or enhanced virus infectivity. Blood...

Cite
Consuegra I, Gasco S, Serramía MJ, et al. Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy. Sci Rep. 2021;11(1):23477doi: 10.1038/s41598-021-03020-5.
Consuegra, I., Gasco, S., Serramía, M. J., Jiménez, J. L., Mellado, M. J., & Muñoz-Fernández, M. �. �. (2021). Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy. Scientific reports, 11(1), 23477. https://doi.org/10.1038/s41598-021-03020-5
Consuegra, Irene, et al. "Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy." Scientific reports vol. 11,1 (2021): 23477. doi: https://doi.org/10.1038/s41598-021-03020-5
Consuegra I, Gasco S, Serramía MJ, Jiménez JL, Mellado MJ, Muñoz-Fernández MÁ. Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy. Sci Rep. 2021 Dec 06;11(1):23477. doi: 10.1038/s41598-021-03020-5. PMID: 34873266; PMCID: PMC8648729.
Copy Download .nbib Format: NLM
Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and .

Drug development and industrial pharmacy

Kandilli B, Ugur Kaplan AB, Cetin M, Taspınar N, Genc S, Yeni Y, Ertugrul MS, Aydin IC, Hacimuftuoglu A.
PMID: 34590547
Drug Dev Ind Pharm. 2021 Jul;47(7):1153-1165. doi: 10.1080/03639045.2021.1988094. Epub 2021 Oct 11.

This study aimed to prepare and characterize the orally disintegrating tablet (ODT) formulations containing the combination of levetiracetam (LEV) and carbamazepine (CBZ) (CBZ + LEV combination) for the treatment of epilepsy. The ODT formulations were prepared using the lyophilization...

Cite
Kandilli B, Ugur Kaplan AB, Cetin M, et al. Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and . Drug Dev Ind Pharm. 2021;47(7):1153-1165doi: 10.1080/03639045.2021.1988094.
Kandilli, B., Ugur Kaplan, A. B., Cetin, M., Taspınar, N., Genc, S., Yeni, Y., Ertugrul, M. S., Aydin, I. C., & Hacimuftuoglu, A. (2021). Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and . Drug development and industrial pharmacy, 47(7), 1153-1165. https://doi.org/10.1080/03639045.2021.1988094
Kandilli, Busra, et al. "Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and ." Drug development and industrial pharmacy vol. 47,7 (2021): 1153-1165. doi: https://doi.org/10.1080/03639045.2021.1988094
Kandilli B, Ugur Kaplan AB, Cetin M, Taspınar N, Genc S, Yeni Y, Ertugrul MS, Aydin IC, Hacimuftuoglu A. Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and . Drug Dev Ind Pharm. 2021 Jul;47(7):1153-1165. doi: 10.1080/03639045.2021.1988094. Epub 2021 Oct 11. PMID: 34590547.
Copy Download .nbib Format: NLM
The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease.

American journal of otolaryngology

Durgut O, Karataş M, Çelik Ç, Dikici O, Solmaz F, Gencay S.
PMID: 34922259
Am J Otolaryngol. 2021 Dec 14;43(2):103320. doi: 10.1016/j.amjoto.2021.103320. Epub 2021 Dec 14.

INTRODUCTION: COVID-19 may have many nonspecific symptoms, such as hearing loss, tinnitus and dizziness. This study aims to investigate the effects of SARS-CoV-2 on the hearing thresholds of patients with COVID-19.METHODS: A total of 20 patients aged 20-55 years...

Cite
Durgut O, Karataş M, Çelik Ç, et al. The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease. Am J Otolaryngol. 2021;43(2):103320doi: 10.1016/j.amjoto.2021.103320.
Durgut, O., Karataş, M., Çelik, �. �., Dikici, O., Solmaz, F., & Gencay, S. (2021). The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease. American journal of otolaryngology, 43(2), 103320. https://doi.org/10.1016/j.amjoto.2021.103320
Durgut, Osman, et al. "The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease." American journal of otolaryngology vol. 43,2 (2021): 103320. doi: https://doi.org/10.1016/j.amjoto.2021.103320
Durgut O, Karataş M, Çelik Ç, Dikici O, Solmaz F, Gencay S. The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease. Am J Otolaryngol. 2021 Dec 14;43(2):103320. doi: 10.1016/j.amjoto.2021.103320. Epub 2021 Dec 14. PMID: 34922259; PMCID: PMC8669941.
Copy Download .nbib Format: NLM
Mitigating bias in estimating epidemic severity due to heterogeneity of epidemic onset and data aggregation.

Annals of epidemiology

Krishnan RG, Cenci S, Bourouiba L.
PMID: 34419601
Ann Epidemiol. 2022 Jan;65:1-14. doi: 10.1016/j.annepidem.2021.07.008. Epub 2021 Aug 19.

Outbreaks of infectious diseases, such as influenza, are a major societal burden. Mitigation policies during an outbreak or pandemic are guided by the analysis of data of ongoing or preceding epidemics. The reproduction number, R

Cite
Krishnan RG, Cenci S, Bourouiba L. Mitigating bias in estimating epidemic severity due to heterogeneity of epidemic onset and data aggregation. Ann Epidemiol. 2021;65:1-14doi: 10.1016/j.annepidem.2021.07.008.
Krishnan, R. G., Cenci, S., & Bourouiba, L. (2022). Mitigating bias in estimating epidemic severity due to heterogeneity of epidemic onset and data aggregation. Annals of epidemiology, 651-14. https://doi.org/10.1016/j.annepidem.2021.07.008
Krishnan, R G, et al. "Mitigating bias in estimating epidemic severity due to heterogeneity of epidemic onset and data aggregation." Annals of epidemiology vol. 65 (2022): 1-14. doi: https://doi.org/10.1016/j.annepidem.2021.07.008
Krishnan RG, Cenci S, Bourouiba L. Mitigating bias in estimating epidemic severity due to heterogeneity of epidemic onset and data aggregation. Ann Epidemiol. 2022 Jan;65:1-14. doi: 10.1016/j.annepidem.2021.07.008. Epub 2021 Aug 19. PMID: 34419601; PMCID: PMC8375253.
Copy Download .nbib Format: NLM
Generation and analysis of innovative genomically humanized knockin .

iScience

Devoy A, Price G, De Giorgio F, Bunton-Stasyshyn R, Thompson D, Gasco S, Allan A, Codner GF, Nair RR, Tibbit C, McLeod R, Ali Z, Noda J, Marrero-Gagliardi A, Brito-Armas JM, Öztürk MM, Simon M, O'Neill E, Bryce-Smith S, Harrison J, Atkins G, Corrochano S, Stewart M, Teboul L, Acevedo-Arozena A, Fisher EMC, Cunningham TJ.
PMID: 34988393
iScience. 2021 Nov 15;24(12):103463. doi: 10.1016/j.isci.2021.103463. eCollection 2021 Dec 17.

Amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) is a fatal neurodegenerative disorder, and continued innovation is needed for improved understanding and for developing therapeutics. We have created next-generation

Cite
Devoy A, Price G, De Giorgio F, et al. Generation and analysis of innovative genomically humanized knockin . iScience. 2021;24(12):103463doi: 10.1016/j.isci.2021.103463.
Devoy, A., Price, G., De Giorgio, F., Bunton-Stasyshyn, R., Thompson, D., Gasco, S., Allan, A., Codner, G. F., Nair, R. R., Tibbit, C., McLeod, R., Ali, Z., Noda, J., Marrero-Gagliardi, A., Brito-Armas, J. M., Öztürk, M. M., Simon, M., O'Neill, E., Bryce-Smith, S., Harrison, J., Atkins, G., Corrochano, S., Stewart, M., Teboul, L., Acevedo-Arozena, A., Fisher, E. M. C., & Cunningham, T. J. (2021). Generation and analysis of innovative genomically humanized knockin . iScience, 24(12), 103463. https://doi.org/10.1016/j.isci.2021.103463
Devoy, Anny, et al. "Generation and analysis of innovative genomically humanized knockin ." iScience vol. 24,12 (2021): 103463. doi: https://doi.org/10.1016/j.isci.2021.103463
Devoy A, Price G, De Giorgio F, Bunton-Stasyshyn R, Thompson D, Gasco S, Allan A, Codner GF, Nair RR, Tibbit C, McLeod R, Ali Z, Noda J, Marrero-Gagliardi A, Brito-Armas JM, Öztürk MM, Simon M, O'Neill E, Bryce-Smith S, Harrison J, Atkins G, Corrochano S, Stewart M, Teboul L, Acevedo-Arozena A, Fisher EMC, Cunningham TJ. Generation and analysis of innovative genomically humanized knockin . iScience. 2021 Nov 15;24(12):103463. doi: 10.1016/j.isci.2021.103463. eCollection 2021 Dec 17. PMID: 34988393; PMCID: PMC8710557.
Copy Download .nbib Format: NLM
Inter-Reader Agreement of Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Detection: A Multi-Reader Retrospective Study.

Cancers

Pesapane F, Rotili A, Penco S, Montesano M, Agazzi GM, Dominelli V, Trentin C, Pizzamiglio M, Cassano E.
PMID: 33924033
Cancers (Basel). 2021 Apr 20;13(8). doi: 10.3390/cancers13081978.

PURPOSE: In order to evaluate the use of un-enhanced magnetic resonance imaging (MRI) for detecting breast cancer, we evaluated the accuracy and the agreement of diffusion-weighted imaging (DWI) through the inter-reader reproducibility between expert and non-expert readers.MATERIAL AND METHODS:...

Cite
Pesapane F, Rotili A, Penco S, et al. Inter-Reader Agreement of Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Detection: A Multi-Reader Retrospective Study. Cancers (Basel). 2021;13(8)doi: 10.3390/cancers13081978.
Pesapane, F., Rotili, A., Penco, S., Montesano, M., Agazzi, G. M., Dominelli, V., Trentin, C., Pizzamiglio, M., & Cassano, E. (2021). Inter-Reader Agreement of Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Detection: A Multi-Reader Retrospective Study. Cancers, 13(8), . https://doi.org/10.3390/cancers13081978
Pesapane, Filippo, et al. "Inter-Reader Agreement of Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Detection: A Multi-Reader Retrospective Study." Cancers vol. 13,8 (2021). doi: https://doi.org/10.3390/cancers13081978
Pesapane F, Rotili A, Penco S, Montesano M, Agazzi GM, Dominelli V, Trentin C, Pizzamiglio M, Cassano E. Inter-Reader Agreement of Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Detection: A Multi-Reader Retrospective Study. Cancers (Basel). 2021 Apr 20;13(8). doi: 10.3390/cancers13081978. PMID: 33924033; PMCID: PMC8073591.
Copy Download .nbib Format: NLM
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease.

Blood

Molteni R, Biavasco R, Stefanoni D, Nemkov T, Domínguez-Andrés J, Arts RJ, Merelli I, Mazza D, Zambrano S, Panigada M, Cantoni E, Tengesdal IW, Maksud P, Piras F, Cesana D, Cassina L, Distefano G, Loffreda A, Gnani D, De Luca G, Tomelleri A, Campochiaro C, Joosten LAB, Dinarello CA, Kajaste-Rudnitski A, Haroche J, Cardaci S, Cenci S, Dagna L, Doglioni C, Ferrarini M, Ferrero E, Boletta A, D'Alessandro A, Montini E, Netea MG, Cavalli G.
PMID: 34077954
Blood. 2021 Oct 28;138(17):1554-1569. doi: 10.1182/blood.2020009594.

Trained immunity (TI) is a proinflammatory program induced in monocyte/macrophages upon sensing of specific pathogens and is characterized by immunometabolic and epigenetic changes that enhance cytokine production. Maladaptive activation of TI (ie, in the absence of infection) may result...

Cite
Molteni R, Biavasco R, Stefanoni D, et al. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood. 2021;138(17):1554-1569doi: 10.1182/blood.2020009594.
Molteni, R., Biavasco, R., Stefanoni, D., Nemkov, T., Domínguez-Andrés, J., Arts, R. J., Merelli, I., Mazza, D., Zambrano, S., Panigada, M., Cantoni, E., Tengesdal, I. W., Maksud, P., Piras, F., Cesana, D., Cassina, L., Distefano, G., Loffreda, A., Gnani, D., De Luca, G., Tomelleri, A., Campochiaro, C., Joosten, L. A. B., Dinarello, C. A., Kajaste-Rudnitski, A., Haroche, J., Cardaci, S., Cenci, S., Dagna, L., Doglioni, C., Ferrarini, M., Ferrero, E., Boletta, A., D'Alessandro, A., Montini, E., Netea, M. G., & Cavalli, G. (2021). Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood, 138(17), 1554-1569. https://doi.org/10.1182/blood.2020009594
Molteni, Raffaella, et al. "Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease." Blood vol. 138,17 (2021): 1554-1569. doi: https://doi.org/10.1182/blood.2020009594
Molteni R, Biavasco R, Stefanoni D, Nemkov T, Domínguez-Andrés J, Arts RJ, Merelli I, Mazza D, Zambrano S, Panigada M, Cantoni E, Tengesdal IW, Maksud P, Piras F, Cesana D, Cassina L, Distefano G, Loffreda A, Gnani D, De Luca G, Tomelleri A, Campochiaro C, Joosten LAB, Dinarello CA, Kajaste-Rudnitski A, Haroche J, Cardaci S, Cenci S, Dagna L, Doglioni C, Ferrarini M, Ferrero E, Boletta A, D'Alessandro A, Montini E, Netea MG, Cavalli G. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood. 2021 Oct 28;138(17):1554-1569. doi: 10.1182/blood.2020009594. PMID: 34077954.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 276 entries